Coronary artery occlusion secondary to graft versus host disease after bone marrow transplant in a 21-year-old

Sihong Huang1, Paul Martin2, M Jay Campbell1

  • 11Department of Pediatrics,Division of Pediatric Cardiology,Duke University,Durham,NC,USA.

Cardiology in the Young
|September 18, 2018
PubMed

Insights

Coronary artery disease is a rare complication in young patients post-bone marrow transplant. This case highlights the importance of monitoring for cardiac issues, even in younger populations, following this procedure.

Area of Science:

  • Cardiology
  • Hematology
  • Oncology

Background:

  • Bone marrow transplantation (BMT) is a life-saving procedure for various hematologic and oncologic conditions.
  • Graft-versus-host disease (GVHD) is a known complication following allogeneic BMT.
  • Coronary artery disease (CAD) is infrequently reported in pediatric and young adult populations post-BMT.

Observation:

  • A 21-year-old patient developed acute myocardial infarction (heart attack).
  • The patient had undergone bone marrow transplantation.
  • The cardiac event was secondary to graft-versus-host disease (GVHD).

Findings:

  • This case demonstrates a rare instance of coronary artery disease and acute myocardial infarction.
  • The patient's cardiac complications were directly linked to graft-versus-host disease post-BMT.
  • The findings underscore a potential, albeit uncommon, long-term complication of BMT in young individuals.

Implications:

  • Physicians should maintain a high index of suspicion for CAD in young patients after BMT.
  • Appropriate cardiovascular evaluation is crucial for early detection and management of cardiac complications.
  • This case expands the understanding of GVHD's systemic effects, including cardiovascular manifestations in young survivors.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
471
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
273
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
383
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
696